Lucira’s Health COVID-19 test approved for sale in Singapore
On Oct. 12, 2021, Lucira Health announced that it had received PSAR approval for its Lucra CHECK IT…
On Oct. 12, 2021, Lucira Health announced that it had received PSAR approval for its Lucra CHECK IT…
On Oct. 12, 2021, CureVac announced the strategic decision to focus its COVID-19 vaccine development towards the development…
On Oct. 12, 2021, Moderna announced that Gavi, the Vaccine Alliance had exercised its option to purchase an…
On Oct. 12, 2021, Inovio Pharmaceuticals announced online preprint publication in MedRxiv of Phase 1 clinical data on…
On Oct. 12, 2021, National Resilience announced a strategic collaboration with Children’s Hospital of Philadelphia (CHOP) to implement…
On Oct. 11, 2021, Merck and Ridgeback Biotherapeutics announced that Merck had submitted an Emergency Use Authorization (EUA)…
On Oct. 11, 2021, scientists at Washington University School of Medicine in St. Louis announced they had developed…
On Oct. 11, 2021, Inovio Pharmaceuticals announced that it had received authorization from Colombia’s INVIMA, to conduct the…
On Oct. 8, 2021, the Ministry of Health of the Democratic Republic of the Congo announced that a…
On Oct. 7, 2021, PerkinElmer announced that the U.S. Food and Drug Administration (FDA) had issued Emergency Use…
On Oct. 7, 2021, Vaxart announced that a Duke University-led study published in bioRxiv showed that Vaxart’s (investigational…
On Oct. 7, 2021, Moderna announced it was building a state-of-the-art mRNA facility in Africa with the goal…
On Oct. 7, 2021, BD (Becton, Dickinson) announced it had strengthened the U.S. government’s access to safety injection…
On Oct. 7, 2021, the World Health Organization launched the Strategy to Achieve Global Covid-19 Vaccination by mid-2022…
On Oct. 7, 2021, the Centers for Disease Control and Prevention (CDC) reported One U.S. child loses a…
On Oct. 6, 2021, Lumen Bioscience announced new development funding from the US Army for its Covid-19 monoclonal…
On Oct. 6, 2021, the U.S. Department of Agriculture’s Agriculture Research Service (ARS) announced confirmation of SARS-CoV-2 (the…
On Oct. 6, 2021, a study by researchers at the National Institutes of Health (NIH) found that episodes…
On Oct. 6, 2021, the The NIH Brain Research through Advancing Innovative Neurotechnologiesï¾® (BRAIN?) Initiative Cell Census Network…
On Oct. 6, 2021, Vaxart announced that it had begun recruiting subjects for its Phase II COVID-19 oral…
On Oct. 6, 2021, AIM ImmunoTech released detailed safety data from a Phase 1 clinical study which supported…
On Oct. 6, 2021, Washington University School of Medicine announced the start of a pediatric COVID-19 vaccine clinical…
On Oct. 6, 2021, the World Health Organization recommended widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among…
On Oct. 5, 2021, PerkinElmer announced that the U.S. Food and Drug Administration had provided Emergency Use Authorization…
On Oct. 5, 2021, Moderna announced that the European Medicines Agency (EMA) had authorized a third dose of…
On Oct. 5, 2021, Johnson & Johnson announced it had submitted data to the U.S. Food and Drug…
On Oct. 5, 2021, a new report from the U.S. Department of Health and Human Services (HHS) showed…
On Oct. 4, 2021, the Fred & Pamela Buffett Cancer Center announced it had successfully renewed its National…
On Oct. 4, 2021, the Nobel Prize in Physiology or Medicine was awarded to David Julius and Ardem…
On Oct. 4, 2021, Dynavax Technologies and the U.S. Department of Defense (DOD) announced Dynavax had executed an…